Espresso Coffee for the Treatment of Somnolence in Parkinson’s Disease: Results of n-of-1 Trials

There is limited information available concerning the treatment of daytime somnolence associated with Parkinson’s disease (PD); the most frequently applied therapeutic strategies include decreasing the dose of dopamine agonists or adding potential wake-promoting agents. There is recent data from a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Joaquim J., Mestre, Tiago, Guedes, Leonor Correia, Coelho, Miguel, Rosa, Mário M., Santos, Ana T., Barra, Márcio, Sampaio, Cristina, Rascol, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2016
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782159/
https://www.ncbi.nlm.nih.gov/pubmed/27014181
http://dx.doi.org/10.3389/fneur.2016.00027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4782159/
https://www.ncbi.nlm.nih.gov/pubmed/27014181
http://dx.doi.org/10.3389/fneur.2016.00027

Ejemplares similares